Physician profile
Raymond M Rizzi
NPI 1255337580
$27,344.87
in general payments reported to CMS, 2019-2025
42 companies · $1,949 in 2025
The $1,949 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,699 · 2020: $2,437 · 2021: $1,204 · 2022: $5,805 · 2023: $5,668 · 2024: $1,583 · 2025: $1,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Travel and Lodging: $2,886 · Food and Beverage: $1,916 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $2,885.65 |
| Food and Beverage | $1,915.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $397.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $12,942.85 | 2019-2025 | Puraply Antimicrobial, Apligraf, Nushield |
| Stryker Corporation | $3,587.45 | 2019-2025 | Ortholoc 2 Lapifuse, Citrefix, Infinity |
| Wright Medical Technology, INC. | $2,204.36 | 2019 | |
| Melinta Therapeutics, LLC | $2,061.96 | 2019-2024 | Orbactiv, Kimyrsa |
| Paragon 28, INC. | $1,876.94 | 2023-2024 | Portfolio, Trauma |
| Kci USA, INC. | $1,139.09 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $604.78 | 2020-2024 | Tapestry |
| Orthofix Medical, INC. | $434.12 | 2019-2020 | |
| Smith+Nephew, INC. | $411.62 | 2020-2025 | Collagenase Santyl |
| Abbott Laboratories | $230.55 | 2019-2023 | |
| Integra Lifesciences Corporation | $192.75 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $154.01 | 2019-2022 | |
| Sanara Medtech INC. | $150.84 | 2022 | |
| Kerecis Limited | $150.68 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Nevro Corp. | $146.09 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Rizzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.